dc.contributor.author | Gill, US | en_US |
dc.contributor.author | Zissimopoulos, A | en_US |
dc.contributor.author | Al-Shamma, S | en_US |
dc.contributor.author | Burke, K | en_US |
dc.contributor.author | McPhail, MJW | en_US |
dc.contributor.author | Barr, DA | en_US |
dc.contributor.author | Kallis, YN | en_US |
dc.contributor.author | Marley, RTC | en_US |
dc.contributor.author | Kooner, P | en_US |
dc.contributor.author | Foster, GR | en_US |
dc.contributor.author | Kennedy, PTF | en_US |
dc.date.accessioned | 2018-04-20T15:29:10Z | |
dc.date.issued | 2015-02-01 | en_US |
dc.date.submitted | 2018-01-30T10:18:52.031Z | |
dc.identifier.issn | 0022-1899 | en_US |
dc.identifier.uri | http://qmro.qmul.ac.uk/xmlui/handle/123456789/36431 | |
dc.format.extent | 374 - 382 | en_US |
dc.relation.ispartof | JOURNAL OF INFECTIOUS DISEASES | en_US |
dc.relation.replaces | 123456789/9840 | |
dc.relation.replaces | https://qmro.qmul.ac.uk/xmlui/handle/123456789/9840 | |
dc.subject | chronic hepatitis B | en_US |
dc.subject | tenofovir | en_US |
dc.subject | bone mineral density | en_US |
dc.subject | DEXA | en_US |
dc.subject | FRAX | en_US |
dc.title | Assessment of Bone Mineral Density in Tenofovir-Treated Patients With Chronic Hepatitis B: Can the Fracture Risk Assessment Tool Identify Those at Greatest Risk? | en_US |
dc.type | Article | |
dc.identifier.doi | 10.1093/infdis/jiu471 | en_US |
pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000350221500007&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
pubs.issue | 3 | en_US |
pubs.merge-from | 123456789/9840 | |
pubs.merge-from | https://qmro.qmul.ac.uk/xmlui/handle/123456789/9840 | |
pubs.notes | Not known | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 211 | en_US |